1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Waltho, J.P.
Higgins, L.D.
Craven, C.J.
Tan, P.
Dudgeon, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
274
16077
16084
10.1074/jbc.274.23.16077
10347159
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants.
1999
10.2210/pdb1b53/pdb
pdb_00001b53
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7678.577
MIP-1A
D26A
2
man
polymer
no
no
SLAADTPTACCFSYTSRQIPQNFIAAYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA
SLAADTPTACCFSYTSRQIPQNFIAAYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Pichia
sample
9606
Homo sapiens
4922
Pichia pastoris
database_2
pdbx_database_status
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Database references
Database references
Other
1
0
1999-07-22
1
1
2008-03-24
1
2
2011-07-13
1
3
2012-02-22
1
4
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_ref_seq_dif.details
Y
BNL
1999-01-11
REL
MEAN STRUCTURE. THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELLED MIP-1A. ADDITIONAL INTERMONOMER CONSTRAINTS WERE ACQUIRED USING A MIXED 13C/15N-12C/14N SAMPLE.
30
1
ST
ARD HETERONUCLEAR TECHNIQUES
NO ADDED SALT
3.5
1
atm
318
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE
SIMULATED ANNEALING STARTING FROM RANDOM ATOM POSITIONS
10% H2O/90% D2O
BRUNGER
refinement
X-PLOR
3.1
structure solution
X-PLOR
500
Bruker
AMX500
SER
1
n
1
SER
1
A
LEU
2
n
2
LEU
2
A
ALA
3
n
3
ALA
3
A
ALA
4
n
4
ALA
4
A
ASP
5
n
5
ASP
5
A
THR
6
n
6
THR
6
A
PRO
7
n
7
PRO
7
A
THR
8
n
8
THR
8
A
ALA
9
n
9
ALA
9
A
CYS
10
n
10
CYS
10
A
CYS
11
n
11
CYS
11
A
PHE
12
n
12
PHE
12
A
SER
13
n
13
SER
13
A
TYR
14
n
14
TYR
14
A
THR
15
n
15
THR
15
A
SER
16
n
16
SER
16
A
ARG
17
n
17
ARG
17
A
GLN
18
n
18
GLN
18
A
ILE
19
n
19
ILE
19
A
PRO
20
n
20
PRO
20
A
GLN
21
n
21
GLN
21
A
ASN
22
n
22
ASN
22
A
PHE
23
n
23
PHE
23
A
ILE
24
n
24
ILE
24
A
ALA
25
n
25
ALA
25
A
ALA
26
n
26
ALA
26
A
TYR
27
n
27
TYR
27
A
PHE
28
n
28
PHE
28
A
GLU
29
n
29
GLU
29
A
THR
30
n
30
THR
30
A
SER
31
n
31
SER
31
A
SER
32
n
32
SER
32
A
GLN
33
n
33
GLN
33
A
CYS
34
n
34
CYS
34
A
SER
35
n
35
SER
35
A
LYS
36
n
36
LYS
36
A
PRO
37
n
37
PRO
37
A
GLY
38
n
38
GLY
38
A
VAL
39
n
39
VAL
39
A
ILE
40
n
40
ILE
40
A
PHE
41
n
41
PHE
41
A
LEU
42
n
42
LEU
42
A
THR
43
n
43
THR
43
A
LYS
44
n
44
LYS
44
A
ARG
45
n
45
ARG
45
A
SER
46
n
46
SER
46
A
ARG
47
n
47
ARG
47
A
GLN
48
n
48
GLN
48
A
VAL
49
n
49
VAL
49
A
CYS
50
n
50
CYS
50
A
ALA
51
n
51
ALA
51
A
ASP
52
n
52
ASP
52
A
PRO
53
n
53
PRO
53
A
SER
54
n
54
SER
54
A
GLU
55
n
55
GLU
55
A
GLU
56
n
56
GLU
56
A
TRP
57
n
57
TRP
57
A
VAL
58
n
58
VAL
58
A
GLN
59
n
59
GLN
59
A
LYS
60
n
60
LYS
60
A
TYR
61
n
61
TYR
61
A
VAL
62
n
62
VAL
62
A
SER
63
n
63
SER
63
A
ASP
64
n
64
ASP
64
A
LEU
65
n
65
LEU
65
A
GLU
66
n
66
GLU
66
A
LEU
67
n
67
LEU
67
A
SER
68
n
68
SER
68
A
ALA
69
n
69
ALA
69
A
SER
1
n
1
SER
1
B
LEU
2
n
2
LEU
2
B
ALA
3
n
3
ALA
3
B
ALA
4
n
4
ALA
4
B
ASP
5
n
5
ASP
5
B
THR
6
n
6
THR
6
B
PRO
7
n
7
PRO
7
B
THR
8
n
8
THR
8
B
ALA
9
n
9
ALA
9
B
CYS
10
n
10
CYS
10
B
CYS
11
n
11
CYS
11
B
PHE
12
n
12
PHE
12
B
SER
13
n
13
SER
13
B
TYR
14
n
14
TYR
14
B
THR
15
n
15
THR
15
B
SER
16
n
16
SER
16
B
ARG
17
n
17
ARG
17
B
GLN
18
n
18
GLN
18
B
ILE
19
n
19
ILE
19
B
PRO
20
n
20
PRO
20
B
GLN
21
n
21
GLN
21
B
ASN
22
n
22
ASN
22
B
PHE
23
n
23
PHE
23
B
ILE
24
n
24
ILE
24
B
ALA
25
n
25
ALA
25
B
ALA
26
n
26
ALA
26
B
TYR
27
n
27
TYR
27
B
PHE
28
n
28
PHE
28
B
GLU
29
n
29
GLU
29
B
THR
30
n
30
THR
30
B
SER
31
n
31
SER
31
B
SER
32
n
32
SER
32
B
GLN
33
n
33
GLN
33
B
CYS
34
n
34
CYS
34
B
SER
35
n
35
SER
35
B
LYS
36
n
36
LYS
36
B
PRO
37
n
37
PRO
37
B
GLY
38
n
38
GLY
38
B
VAL
39
n
39
VAL
39
B
ILE
40
n
40
ILE
40
B
PHE
41
n
41
PHE
41
B
LEU
42
n
42
LEU
42
B
THR
43
n
43
THR
43
B
LYS
44
n
44
LYS
44
B
ARG
45
n
45
ARG
45
B
SER
46
n
46
SER
46
B
ARG
47
n
47
ARG
47
B
GLN
48
n
48
GLN
48
B
VAL
49
n
49
VAL
49
B
CYS
50
n
50
CYS
50
B
ALA
51
n
51
ALA
51
B
ASP
52
n
52
ASP
52
B
PRO
53
n
53
PRO
53
B
SER
54
n
54
SER
54
B
GLU
55
n
55
GLU
55
B
GLU
56
n
56
GLU
56
B
TRP
57
n
57
TRP
57
B
VAL
58
n
58
VAL
58
B
GLN
59
n
59
GLN
59
B
LYS
60
n
60
LYS
60
B
TYR
61
n
61
TYR
61
B
VAL
62
n
62
VAL
62
B
SER
63
n
63
SER
63
B
ASP
64
n
64
ASP
64
B
LEU
65
n
65
LEU
65
B
GLU
66
n
66
GLU
66
B
LEU
67
n
67
LEU
67
B
SER
68
n
68
SER
68
B
ALA
69
n
69
ALA
69
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
B
HB3
HB2
SER
ALA
13
4
1.12
1
A
B
HB2
O
SER
ALA
13
4
1.27
1
A
B
HD2
OG1
PHE
THR
12
8
1.57
1
A
B
CB
O
SER
ALA
13
4
2.17
1
A
TYR
14
0.445
SIDE CHAIN
1
A
ARG
45
0.283
SIDE CHAIN
1
A
ARG
47
0.295
SIDE CHAIN
1
B
TYR
14
0.445
SIDE CHAIN
1
B
ARG
45
0.283
SIDE CHAIN
1
B
ARG
47
0.295
SIDE CHAIN
1
-10.57
0.60
121.00
110.43
A
A
A
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
1
-67.48
1.10
117.90
50.42
A
A
A
CD1
CG
CD2
TYR
TYR
TYR
14
14
14
N
1
15.00
0.60
121.00
136.00
A
A
A
CB
CG
CD1
TYR
TYR
TYR
14
14
14
N
1
-43.98
0.80
121.30
77.32
A
A
A
CG
CD1
CE1
TYR
TYR
TYR
14
14
14
N
1
-45.66
0.80
121.30
75.64
A
A
A
CG
CD2
CE2
TYR
TYR
TYR
14
14
14
N
1
-44.16
0.90
119.80
75.64
A
A
A
CD1
CE1
CZ
TYR
TYR
TYR
14
14
14
N
1
-68.80
1.60
119.80
51.00
A
A
A
CE1
CZ
CE2
TYR
TYR
TYR
14
14
14
N
1
-42.41
0.90
119.80
77.39
A
A
A
CZ
CE2
CD2
TYR
TYR
TYR
14
14
14
N
1
-10.56
0.60
121.00
110.44
B
B
B
CB
CG
CD2
TYR
TYR
TYR
14
14
14
N
1
-67.49
1.10
117.90
50.41
B
B
B
CD1
CG
CD2
TYR
TYR
TYR
14
14
14
N
1
14.98
0.60
121.00
135.98
B
B
B
CB
CG
CD1
TYR
TYR
TYR
14
14
14
N
1
-43.98
0.80
121.30
77.32
B
B
B
CG
CD1
CE1
TYR
TYR
TYR
14
14
14
N
1
-45.64
0.80
121.30
75.66
B
B
B
CG
CD2
CE2
TYR
TYR
TYR
14
14
14
N
1
-44.16
0.90
119.80
75.64
B
B
B
CD1
CE1
CZ
TYR
TYR
TYR
14
14
14
N
1
-68.78
1.60
119.80
51.02
B
B
B
CE1
CZ
CE2
TYR
TYR
TYR
14
14
14
N
1
-42.40
0.90
119.80
77.40
B
B
B
CZ
CE2
CD2
TYR
TYR
TYR
14
14
14
N
1
A
LEU
2
-161.13
-155.36
1
A
ALA
3
-62.46
-142.75
1
A
THR
6
160.24
126.00
1
A
THR
8
-53.22
90.84
1
A
ALA
9
-48.22
108.43
1
A
CYS
11
-101.23
77.60
1
A
ALA
25
-149.50
-38.65
1
A
ALA
26
-109.34
-145.80
1
A
TYR
27
178.78
-43.50
1
A
PHE
28
46.99
-173.53
1
A
GLU
29
-164.17
39.01
1
A
THR
30
42.37
-143.67
1
A
SER
31
-177.77
-166.09
1
A
GLN
33
78.31
-29.84
1
A
LYS
36
-116.01
77.93
1
A
PRO
37
-82.15
31.03
1
A
THR
43
-41.61
159.53
1
A
SER
46
45.87
25.53
1
A
SER
54
-166.73
35.87
1
A
LEU
67
171.42
64.08
1
B
LEU
2
-161.18
-155.44
1
B
ALA
3
-62.40
-142.74
1
B
THR
6
160.30
125.99
1
B
THR
8
-53.23
90.85
1
B
ALA
9
-48.14
108.40
1
B
CYS
11
-101.23
77.62
1
B
ALA
25
-149.52
-38.64
1
B
ALA
26
-109.34
-145.77
1
B
TYR
27
178.76
-43.46
1
B
PHE
28
47.22
-173.56
1
B
GLU
29
-164.21
38.99
1
B
THR
30
42.39
-143.68
1
B
SER
31
-177.79
-166.09
1
B
GLN
33
78.28
-29.84
1
B
LYS
36
-115.94
77.89
1
B
PRO
37
-82.11
31.03
1
B
THR
43
-41.59
159.46
1
B
SER
46
45.88
25.51
1
B
SER
54
-166.79
35.91
1
B
LEU
67
171.38
64.08
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
NMR STRUCTURE OF HUMAN MIP-1A D26A, MINIMIZED AVERAGE STRUCTURE
1
N
N
1
N
N
A
GLN
21
A
GLN
21
HELX_P
A
PHE
23
A
PHE
23
5
1
3
A
VAL
58
A
VAL
58
HELX_P
A
SER
63
A
SER
63
1
2
6
B
GLN
21
B
GLN
21
HELX_P
B
PHE
23
B
PHE
23
5
3
3
B
VAL
58
B
VAL
58
HELX_P
B
SER
63
B
SER
63
1
4
6
disulf
2.021
A
CYS
10
A
SG
CYS
10
1_555
A
CYS
34
A
SG
CYS
34
1_555
disulf
2.717
A
CYS
10
A
SG
CYS
10
1_555
B
CYS
10
B
SG
CYS
10
1_555
disulf
2.021
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
50
A
SG
CYS
50
1_555
disulf
2.953
A
CYS
34
A
SG
CYS
34
1_555
B
CYS
10
B
SG
CYS
10
1_555
disulf
2.973
A
CYS
34
A
SG
CYS
34
1_555
B
CYS
34
B
SG
CYS
34
1_555
disulf
2.020
B
CYS
10
B
SG
CYS
10
1_555
B
CYS
34
B
SG
CYS
34
1_555
disulf
2.022
B
CYS
11
B
SG
CYS
11
1_555
B
CYS
50
B
SG
CYS
50
1_555
CHEMOKINE
CHEMOKINE, CYTOKINE, CHEMOTAXIS
CCL3_HUMAN
UNP
1
1
P10147
MQVSTAALAVLLCTMALCNQFSASLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEW
VQKYVSDLELSA
24
92
1B53
1
69
P10147
A
1
1
69
24
92
1B53
1
69
P10147
B
1
1
69
1
ASP
engineered mutation
ALA
26
1B53
A
P10147
UNP
49
26
2
ASP
engineered mutation
ALA
26
1B53
B
P10147
UNP
49
26
1
P 1